By
Jaclyn Jaeger2021-09-07T19:08:00
The U.S. Food and Drug Administration’s “intended use” final rule reaffirms the agency’s wide latitude of discretion in establishing an off-label use case against pharmaceutical and medical device companies.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2025-01-15T19:05:00Z By Oscar Gonzalez
The U.S. Food and Drug Administration announced Wednesday it has revoked authorization for color additive Red No. 3 from food, beverages, and drugs. Health concerns over dye have existed since it was banned from cosmetics in 1990 after it was found that large doses led to the development of cancer ...
2026-04-07T20:49:00Z By Adrianne Appel
A rule overhaul proposed by the U.S. Treasury Department’s Financial Crimes Enforcement Network is designed to reduce compliance burden would free up banks from tracking all but the most egregious illicit financial activities.
2026-04-06T19:58:00Z By Aaron Nicodemus
Assistant Attorney General (AAG) of the Criminal Division at the U.S. Department of Justice, A. Tysen Duva, will be a keynote speaker on Day Two of Compliance Week’s National Conference in Washington, D.C.
2026-04-03T18:20:00Z By Ruth Prickett
On Oct. 11, 2027, the EU, U.K., and Switzerland will move to T+1 securities settlement. The date may seem distant, but the challenges are considerable.
2026-04-03T17:33:00Z By Neil Hodge
The U.K.’s plans to revise how companies report more meaningfully on the impact their operations have on the environment will mean organizations will have to dig for better data to satisfy regulators—even if they decide that compliance with the proposed rules is not appropriate for them under the option of ...
2026-04-02T19:12:00Z By Neil Hodge
The European Union’s key data privacy regulators have said that they support streamlining compliance and reporting requirements under plans to beef up cybersecurity across the 27-nation bloc.
Site powered by Webvision Cloud